Skip to main content

Overview

A study aiming to explore non-prescribed (illicit) ketamine use in Australia. There are indications that non-prescribed ketamine use has increased in Australia but little information about what this use actually looks like. We want to gain insight into who might be using ketamine in Australia, how they use ketamine, and why they use it. We want to identify the consequences of ketamine use, both the benefits and the harms. We will do this to inform future research and the provision of harm reduction and medical services to people who use ketamine in Australia. 

What the Study Involves

The AuKS utilised an online survey of people who have used ketamine at least once in the previous 12-months who answered questions to their demographics, use of ketamine and other drugs, reasons for using ketamine, and consequences (both good and bad) they believe are related to their ketamine use. 

Who Participated?

Almost 500 participants who met the following criteria completed the survey:

  • Aged 18 or over
  • Used non-prescribed ketamine in Australia at least once in the previous 12 months
  • Reside in Australia
  • Can read and understand English 

What's Next?

Data collected in this survey will now be analysed to produce a range of outputs (including academic publications). Stay tuned to find out more. 

Investigators

Mr. Stassi Kypri 

National Centre for Clinical Research on Emerging Drugs, UNSW

Ms. Jess Doumany 

Australian Injecting and Illicit Drug Users League

Mx. John Gobeil 

Australian Injecting and Illicit Drug Users League

Dr. Liam Acheson 

National Centre for Clinical Research on Emerging Drugs, UNSW 

Dr. Krista Siefried 

National Centre for Clinical Research on Emerging Drugs, UNSW

Prof. Nadine Ezard 

National Centre for Clinical Research on Emerging Drugs, UNSW

Dr. Cilla Zhou 

National Centre for Clinical Research on Emerging Drugs, UNSW  

Dr. Jack Freestone 

National Centre for Clinical Research on Emerging Drugs, UNSW

Dr. Kathryn Fletcher 

National Centre for Clinical Research on Emerging Drugs, UNSW

A/Prof. Amy Peacock 

National Drug and Alcohol Research Centre, UNSW

Dr. Rachel Sutherland 

National Drug and Alcohol Research Centre, UNSW

Mr.  Mitchell Lamb 

Canberra Alliance for Harm Minimisation and Advocacy

Mr. Nick Kent 

Harm Reduction Victoria

Dr. Jai Whelan 

University of Otago, Christchurch, Aotearoa New Zealand